Synthesis, cytotoxicity assessment and molecular docking of novel thienyl-pyrazoles as VEGFR2 Inhibitors.

Molecular Docking Approach of Some Quinoxaline Derivatives as Anticancer Agents Targeting VEGFR-2.

SYNTHESIS, DOCKING OF NEW CHALCONES BASED HETEROCYCLIC COMPOUNDS, AND THEIR EVALUATION AS SELECTIVE BRAF INHIBITORS

Schiffʼs Base-indenoquinoxaline Hybrids as Apoptotic Inducing Agents, Design, Synthesis, In vitro Cytotoxicity, physicochemical and pharmacokinetic Studies

Molecular Docking, Synthesis and ADME Studies of New Pyrazoline Derivatives as Potential Anticancer Agents

The Antiproliferative Activity and Molecular Docking Studies of Some Sulfonamides against Cancer Cell Lines Compared to Normal Cells

Antiproliferative Evaluation and Molecular Docking studies of some Sulfonyl-α-L-amino acid Derivatives coupled with Anisamide Scaffold

Theoretical Drug Design, Molecular Docking And ADME Study Of New 1,3,4-Oxadiazole Derivatives: Promising Anticancer Agents Against Both Breast And Lung Cancers

Synthesis, Moleculer Docking and Anticancer Screening of Some Novel Tetrahydronaphthyl Thiazolyl Pyrazoles and other Related Derivatives

AN INSIGHT ON MEDICINAL ATTRIBUTES OF PHTHALAZINE SCAFFOLD, WITH A FOCUS ON THEIR ANTICANCER PROPERTIES AS VEGFR-2 INHIBITORS